Skip to main content
Toggle navigation
Login
Search
Home
ICPE 2023 Program
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Benefit-Risk Assessment, Communication, and Evaluation (BRACE)
Benefit-Risk Assessment, Communication, and Evaluation (BRACE)
Type here to filter the list
(001) Association of ticagrelor versus clopidogrel with major adverse cardiovascular events in patients with acute coronary syndrome undergoing percutaneous coronary intervention across categories of liver disease
Favorite
(002) Use of Bibliometrics and Altmetrics in Research Impact Assessment of the Canadian Network for Observational Drug Effect Studies: Preliminary Observations
Favorite
(003) What are the main expectations of patients with hemophilia regarding treatment?
Favorite
(004) Meta-analysis of the effects of dexmedetomidine on perioperative inflammatory response and hemodynamics in children with congenital heart disease
Favorite
(006) The Global Seroprevalence of Lyme Disease: A Literature Review
Favorite
(007) Efficacy and Safety of Pyrazobicin by Thermal Infusion in Treatment of Bladder Cancer: A Meta analysis
Favorite
(008) Real-world antiretroviral treatment use patterns among people living with HIV in the U.S.
Favorite
(009) Effectiveness of insulin glargine liraglutide injection in the treatment of type 2 diabetes: a systematic review
Favorite
(010) Association between the Use of Glucagon-like Peptide 1 Agonist and the Risk of Psoriasis in Diabetes Patients Compare to Dipeptidyl Peptidase-4 inhibitors in Taiwan
Favorite
(011) Efficacy and safety of Pingxiao capsules in combination with chemotherapy in the treatment of gastric cancer: a systematic review
Favorite
(012) Meta-analysis of the efficacy and safety of ustekinumab in Crohn's disease
Favorite
(013) Potential Risk Factors for Delirium during Inpatient Rehabilitation: A Matched Case-Control Study
Favorite
(014) Meta-analysis of postoperative safety of cantharidith preparation combined with chemotherapy in the treatment of breast cancer
Favorite
(015) Systematic review of traditional Chinese medicine rhubarb administration via nasal jejunal tube in the treatment of severe acute pancreatitis
Favorite
(016) Efficacy and Safety of Kangai Injection Combined with Platinum-based Chemotherapy for the Treatment of Ovarian Cancer: A Systematic Review and Meta‑analysis
Favorite
(017) Effectiveness of Aspirin in The Treatment of Preeclampsia and Related Pregnancy Outcomes: A Meta Analysis
Favorite
(018) Meta-analysis of traditional Chinese medicine for cough
Favorite
(019) A systematic review of the efficacy and safety of dobutamine in the treatment of sepsis
Favorite
(020) Systematic evaluation of the efficacy of Shenqi Fuzheng injection combined with CAF chemotherapy in the treatment of breast cancer and the clinical effect of peripheral blood picture
Favorite
(021) Community Pharmacy Perspectives on Assessing Kidney Function and Medication Dosing for Advanced Chronic Kidney Disease: A Qualitative Study
Favorite
(022) A systematic review of the safety of crow bile oil emulsion injection combined with GP regimen in the treatment of non-small cell lung cancer
Favorite
(023) Systematic evaluation and meta-analysis on the treatment of moderate and severe cancer pain in cancer patients with traditional chinese medicine combined with three-step analgesic method
Favorite
(024) Risk of Pancreatitis with the Use of Glucagon-like peptide 1 (GLP1) agonists: Analyses of the Post-Marketing FDA Adverse Event Reporting System (FAERS) Database
Favorite
(025) Quantitative benefit-risk assessment of vaccination against COVID-19: a systematic literature review
Favorite
(026) Effectiveness of additional risk minimisation measures: Improving response rates and validity in surveys
Favorite
(027) Increased risk of retinal vascular occlusion in patients receiving cataract surgery: causation or biased association?
Favorite
(028) Non-steroidal anti-inflammatory drug use for migraine and arterial thromboembolic risks: A Danish population-based matched cohort study
Favorite
(029) Trajectories of EU Paediatric Investigation Plans for Oncology approved since 2007 and Resulting Paediatric Cancer Indications
Favorite